Literature DB >> 31375053

Multiobjective Calibration of Disease Simulation Models Using Gaussian Processes.

Aditya Sai1, Carolina Vivas-Valencia1, Thomas F Imperiale2,3,4, Nan Kong1.   

Abstract

Background. Developing efficient procedures of model calibration, which entails matching model predictions to observed outcomes, has gained increasing attention. With faithful but complex simulation models established for cancer diseases, key parameters of cancer natural history can be investigated for possible fits, which can subsequently inform optimal prevention and treatment strategies. When multiple calibration targets exist, one approach to identifying optimal parameters relies on the Pareto frontier. However, computational burdens associated with higher-dimensional parameter spaces require a metamodeling approach. The goal of this work is to explore multiobjective calibration using Gaussian process regression (GPR) with an eye toward how multiple goodness-of-fit (GOF) criteria identify Pareto-optimal parameters. Methods. We applied GPR, a metamodeling technique, to estimate colorectal cancer (CRC)-related prevalence rates simulated from a microsimulation model of CRC natural history, known as the Colon Modeling Open Source Tool (CMOST). We embedded GPR metamodels within a Pareto optimization framework to identify best-fitting parameters for age-, adenoma-, and adenoma staging-dependent transition probabilities and risk factors. The Pareto frontier approach is demonstrated using genetic algorithms with both sum-of-squared errors (SSEs) and Poisson deviance GOF criteria. Results. The GPR metamodel is able to approximate CMOST outputs accurately on 2 separate parameter sets. Both GOF criteria are able to identify different best-fitting parameter sets on the Pareto frontier. The SSE criterion emphasizes the importance of age-specific adenoma progression parameters, while the Poisson criterion prioritizes adenoma-specific progression parameters. Conclusion. Different GOF criteria assert different components of the CRC natural history. The combination of multiobjective optimization and nonparametric regression, along with diverse GOF criteria, can advance the calibration process by identifying optimal regions of the underlying parameter landscape.

Entities:  

Keywords:  Gaussian process; Pareto frontier; calibration; cancer simulation; goodness-of-fit criterion; microsimulation; regression

Mesh:

Year:  2019        PMID: 31375053      PMCID: PMC6786931          DOI: 10.1177/0272989X19862560

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  22 in total

1.  Bayesian calibration of a natural history model with application to a population model for colorectal cancer.

Authors:  Sophie Whyte; Cathal Walsh; Jim Chilcott
Journal:  Med Decis Making       Date:  2010-12-02       Impact factor: 2.583

Review 2.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

Authors:  J Jaime Caro; Andrew H Briggs; Uwe Siebert; Karen M Kuntz
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

4.  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

5.  A Prediction Model for Functional Outcomes in Spinal Cord Disorder Patients Using Gaussian Process Regression.

Authors:  Sunghoon Ivan Lee; Bobak Mortazavi; Haydn A Hoffman; Derek S Lu; Charles Li; Brian H Paak; Jordan H Garst; Mehrdad Razaghy; Marie Espinal; Eunjeong Park; Daniel C Lu; Majid Sarrafzadeh
Journal:  IEEE J Biomed Health Inform       Date:  2014-11-20       Impact factor: 5.772

6.  Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis.

Authors:  M D Stevenson; J Oakley; J B Chilcott
Journal:  Med Decis Making       Date:  2004 Jan-Feb       Impact factor: 2.583

7.  Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy.

Authors:  Hermann Brenner; Lutz Altenhofen; Christian Stock; Michael Hoffmeister
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-30       Impact factor: 4.254

8.  Nonidentifiability in Model Calibration and Implications for Medical Decision Making.

Authors:  Fernando Alarid-Escudero; Richard F MacLehose; Yadira Peralta; Karen M Kuntz; Eva A Enns
Journal:  Med Decis Making       Date:  2018-10       Impact factor: 2.583

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Computerized prediction of intensive care unit discharge after cardiac surgery: development and validation of a Gaussian processes model.

Authors:  Geert Meyfroidt; Fabian Güiza; Dominiek Cottem; Wilfried De Becker; Kristien Van Loon; Jean-Marie Aerts; Daniël Berckmans; Jan Ramon; Maurice Bruynooghe; Greet Van den Berghe
Journal:  BMC Med Inform Decis Mak       Date:  2011-10-25       Impact factor: 2.796

View more
  1 in total

1.  A two-phase approach to re-calibrating expensive computer simulation for sex-specific colorectal neoplasia development modeling.

Authors:  Carolina Vivas-Valencia; You Zhou; Aditya Sai; Thomas F Imperiale; Nan Kong
Journal:  BMC Med Inform Decis Mak       Date:  2022-09-18       Impact factor: 3.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.